Stratasys has launched its newest 3D printer aimed on the medical market because it goals to make its medical modelling expertise extra accessible to hospitals, medical system producers and analysis establishments.
The J5 Digital Anatomy 3D printer is designed for the manufacturing of correct medical fashions which might help enhance affected person outcomes, velocity up operations and cut back the time to marketplace for new healthcare merchandise, notably for customers going through funds and house limitations.
“The J5 Digital Anatomy printer is designed to be user-friendly and facility-friendly, making superior anatomical modelling accessible to a broader vary of medical establishments,” mentioned Erez Ben Zvi, VP Medical, Stratasys.
The machine is the newest addition to the additive manufacturing firm’s J collection of multi-material printers and follows the J5 MediJet multi-material, multi-colour system, which launched in 2021 and has been utilized by the likes of College Hospital Birmingham to cut back surgical procedure occasions for head and neck most cancers sufferers by as much as three hours. The J5 Digital Anatomy printer gives a equally office-friendly, compact footprint and what Stratasys believes to be ‘unmatched precision and realism in anatomical modelling.’
Customers will be capable to print life-like, patient-specific fashions in biomechanically correct supplies that mimic the behaviour of actual human tissue, skeletal buildings and vasculature. These fashions can be utilized to assist surgeons plan working procedures with elevated confidence but additionally as a communication system between healthcare professionals and sufferers. The printer will also be used as a useful resource for coaching medical employees, with fashions providing haptic suggestions for procedures similar to suturing, incision, and screw insertion, alongside true-to-life radiopacity traits with supported imaging.
In the meantime, for medical system producers, exact, repeatable anatomical fashions can be utilized to cut back the necessity for animal testing and shorten lead occasions for brand spanking new medical system improvement.
The machine will make its debut at RAPID + TCT on June 25th.
Yoav Zeif, PhD, CEO, Stratasys will function as a part of RAPID + TCT’s Government Views Keynote Collection on June 25-Seventeenth in Los Angeles, California. Register for you ticket right here.
